Omicron News and Research

RSS

Quantum mechanical characterization of SARS-CoV-2 Omicron variant interaction with human ACE2 receptor

Researchers from Universite Grenoble Alpes have been investigating the changes in the Omicron variant RBD and how they affect ACE2 binding.

8 Dec 2021

Computational comparison of SARS-CoV-2 Delta and Omicron variant binding affinity with ACE2

Researchers from the Management and Science University in Malaysia have used computational tools to investigate the new variant.

8 Dec 2021

Combination of vaccination and natural infection offers utmost protection against COVID variants

A combination of vaccination and naturally acquired infection appears to boost the production of maximally potent antibodies against the COVID-19 virus, new UCLA research finds.

8 Dec 2021

Study analyzes the contribution of AI to cancer patient care and vaccine design

Artificial Intelligence/Machine Learning (AI/ML) is the development of computer systems that are able to perform tasks that would normally require human intelligence. AI/ML is used by people every day, for example, while using smart home devices or digital voice assistants.

8 Dec 2021

Cas12a-based bio-sensor for detecting SARS-CoV-2 mutations

Scientists develop an improved biosensor with Cas12a-based CRISPR on-site rapid detection system and discuss its ability to detect SARS-CoV-2 VOCs.

7 Dec 2021

SARS-CoV-2 Delta variant changes receptor binding domain conformation to escape host antibodies

Researchers investigate the conformational dynamics of the SARS-CoV-2 RBD using the atomistic molecular dynamics simulation method.

7 Dec 2021

Multiplex proteomic panel assay for assessment of disease severity and outcome prediction in COVID-19

According to the authors of a new study, multiplex protein panel assay could support clinical decision-making, guide the development of novel treatments, and expand the risk assessment procedures for COVID-19.

7 Dec 2021

Possible impact of spike protein mutations on SARS-CoV-2 Omicron variant

The current study not only analyses the mutations in the Omicron spike variant but classifies various combinations of spike mutations into groups.

7 Dec 2021

Comparison of waning COVID-19 immunity between vaccinated and infected individuals

The current study compares the waning of immunity in infected-and-recovered vs. vaccinated cohorts.

7 Dec 2021

Scientists develop and characterize variant-specific vaccines against SARS-CoV-2

In a recent study conducted at Yale University, USA, scientists have investigated the immunogenicity of mRNA-based coronavirus disease 2019 (COVID-19) vaccine candidates encoding the spike proteins of different severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants. The findings reveal that the vaccines induce robust immune responses against SARS-CoV-2 variants. The study is currently available on the bioRxiv* preprint server.

6 Dec 2021

Omicron variant increases risk of SARS-CoV-2 reinfection

New surveillance data from South Africa published in the medRxiv* preprint server suggests that the new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omnicron variant has the potential to escape naturally-acquired immunity. The research indicates people who previously recovered from a coronavirus disease 2019 (COVID-19) are at risk for reinfection with the Omicron variant. The results show that the risk of reinfection is greater with the Omicron variant versus Delta and Beta.

6 Dec 2021

Martin Kemp appears as Father Christmas in a new film to increase COVID-19 vaccine uptake

Former soap star and member of Spandau Ballet Martin Kemp has joined the national effort to get people vaccinated - by appearing as Father Christmas in a new film released today (Tuesday 7 December).

6 Dec 2021

Forecasting outbreak of SARS-CoV-2 Omicron variant with Tajima's D

A new study argues that that rapid genomic sequence surveillance is absolutely crucial and Tajima D tests should be included to predict future COVID-19 outbreaks.

6 Dec 2021

Sino Biological Launches A Panel of Research Reagents for SARS-CoV-2 Omicron Variant (B.1.1.529)

Sino Biological, Inc. (https://www.sinobiological.com; SHE: 301047) announced today that it has launched a panel of research reagents for the newly identified Omicron variant (B.1.1.529) of the SARS-CoV-2 virus

From Sino Biological Inc. 6 Dec 2021

UK's COVID-19 booster program accelerated, and people urged to get top-up jabs

People have been urged to get a coronavirus (COVID-19) booster vaccine to top-up their protection this winter as 20 million people in the UK are expected to have had their third jabs today (Sunday 5 December 2021).

5 Dec 2021

The emergence and evolution of SARS-CoV-2 and its VOCs

A review article discusses the evolution of SARS-CoV-2 and the emergence of variants of concern.

5 Dec 2021

New test can quickly and easily assess antibody effectiveness against COVID-19 variants

Biomedical engineers at Duke University have devised a test to quickly and easily assess how well a person's neutralizing antibodies fight infection from multiple variants of COVID-19 such as Delta and the newly discovered Omicron variant.

4 Dec 2021

CDC revises the current Global Testing Order for all international air travelers

Today, the Centers for Disease Control and Prevention (CDC) is revising the current Global Testing Order to shorten the timeline for required testing for all international air travelers to one day before departure to the United States.

3 Dec 2021

Is it time to change the definition of ‘fully vaccinated’?

As more indoor venues require proof of vaccination for entrance and with winter — as well as omicron, a new covid variant — looming, scientists and public health officials are debating when it will be time to change the definition of "fully vaccinated" to include a booster shot.

3 Dec 2021

£700 million will help hospitals across England tackle waiting lists and improve care

Hospitals across the country will benefit from a share of £700 million to expand wards, install modular operating theaters, upgrade outpatient spaces and MRI and screening technology, to help reduce waiting lists.

2 Dec 2021

Omicron News and Research

Quantum mechanical characterization of SARS-CoV-2 Omicron variant interaction with human ACE2 receptor

Computational comparison of SARS-CoV-2 Delta and Omicron variant binding affinity with ACE2

Combination of vaccination and natural infection offers utmost protection against COVID variants

Study analyzes the contribution of AI to cancer patient care and vaccine design

Cas12a-based bio-sensor for detecting SARS-CoV-2 mutations

SARS-CoV-2 Delta variant changes receptor binding domain conformation to escape host antibodies

Multiplex proteomic panel assay for assessment of disease severity and outcome prediction in COVID-19

Possible impact of spike protein mutations on SARS-CoV-2 Omicron variant

Comparison of waning COVID-19 immunity between vaccinated and infected individuals

Scientists develop and characterize variant-specific vaccines against SARS-CoV-2

Omicron variant increases risk of SARS-CoV-2 reinfection

Martin Kemp appears as Father Christmas in a new film to increase COVID-19 vaccine uptake

Forecasting outbreak of SARS-CoV-2 Omicron variant with Tajima's D

Sino Biological Launches A Panel of Research Reagents for SARS-CoV-2 Omicron Variant (B.1.1.529)

UK's COVID-19 booster program accelerated, and people urged to get top-up jabs

The emergence and evolution of SARS-CoV-2 and its VOCs

New test can quickly and easily assess antibody effectiveness against COVID-19 variants

CDC revises the current Global Testing Order for all international air travelers

Is it time to change the definition of ‘fully vaccinated’?

£700 million will help hospitals across England tackle waiting lists and improve care

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News